Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
| Autor: | Morschhauser, Franck, Flinn, Ian W, Advani, Ranjana, Sehn, Laurie H, Diefenbach, Catherine, Kolibaba, Kathryn, Press, Oliver W, Salles, Gilles, Tilly, Hervé, Chen, Andy I, Assouline, Sarit, Cheson, Bruce D, Dreyling, Martin, Hagenbeek, Anton, Zinzani, Pier Luigi, Jones, Surai, Cheng, Ji, Lu, Dan, Penuel, Elicia, Hirata, Jamie, Wenger, Michael, Chu, Yu-Waye, Sharman, Jeff |
|---|---|
| Zdroj: | In The Lancet Haematology May 2019 6(5):e254-e265 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|